Compared to its role in nasopharyngeal carcinoma (NPC), EBV shares several common oncogenic mechanisms across both disease contexts, including LMP1 mediated NF-κB activation, antiapoptotic signaling, and evasion of immune surveillance (130, 139). The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.